Contact
Please use this form to send email to PR contact of this press release:
Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma
TO:
Please use this form to send email to PR contact of this press release:
Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma
TO: